EGFR and pancreatic neoplasm: This activity results in inhibition of pancreatic cancer cell growth and migration, decreased colony formation, as well as downregulation of a plethora of pathways pivotal for PDAC progression, including EGFR, ERK or KRAS expression [270,271].